NCT02393586View on ClinicalTrials.gov

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Tuberculosis
Interventions
DRUG

Faropenem

Single oral dose

DRUG

Amoxicillin/clavulanic acid 500mg/125mg

Single oral dose

DRUG

Rifampicin

Single oral dose

Trial Locations (1)

Unknown

National University Hospital, Singapore

All Listed Sponsors
lead

National University Hospital, Singapore

OTHER

NCT02393586 - Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers | Biotech Hunter | Biotech Hunter